Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cardiovascular
Neuroprotection
Drug Discovery
Inflammation/Pain
Autoimmune
Technical Glossary
Publications
Investors
Investor Welcome
ASX Announcements
Share Price Information
Shareholder Meetings
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
News & Insights
Presentations & Interviews
Media
Newsletters
Contact Us
Contact Us
Working at Nyrada
Email Alerts
News & Insights
Home
>
News & Insights
>
Presentations & Interviews
>
Presentations & Interviews
Media
Newsletters
Nyrada (ASX:NYR) discusses progress in cholesterol-lowering drug program, January 2021